This is a procurement-oriented overview for distributors, hospitals, and clinics evaluating coronary artery disease & cardiac interventions devices. The specific combination of wires, balloons, atherectomy, and stents is determined by the interventional cardiologist based on lesion complexity, calcification, and overall clinical picture. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Coronary Artery Disease and Percutaneous Coronary Intervention
The specific combination of wires, balloons, atherectomy, and stents is determined by the interventional cardiologist based on lesion complexity, calcification, and overall clinical picture. Percutaneous coronary intervention (PCI) is a catheter-based approach that reaches the coronary arteries through a small arterial access point, typically the radial or femoral artery. Coronary artery disease develops when atherosclerotic plaque accumulates within the arteries that supply the heart muscle, gradually narrowing the lumen and limiting blood flow.
Regulatory Status and Manufacturing
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Portfolio and Sizing
Within this category, INVAMED lists devices such as ATLAS Drug Eluting Coronary Stent System Cobalt Chromium, Atlas Coronary Stent System Cobalt Chromium, Atlas Coronary Stent System Stainless Steel, Extender Drug Eluting PTCA Balloon Catheter, Inwire PTCA Guidewire, TemREN Rotablator, AngioTEN Vascular Closure System. Size ranges, materials, and configurations are detailed in product documentation and the applicable IFU.
Key Considerations
- Lesion calcification is a central factor in planning, and heavily calcified plaque may call for rotational atherectomy before ballooning or stenting.
- Dual antiplatelet therapy duration is individualized to the clinical presentation and the patient's bleeding risk.
- Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes.
Frequently Asked Questions
Does INVAMED make a drug-coated coronary balloon?
Yes. The Extender Drug Eluting PTCA Balloon Catheter carries a paclitaxel coating for local drug delivery, such as in-stent restenosis or small-vessel disease.
What is the reported restenosis performance of the ATLAS DES?
INVAMED reports clinical data showing target lesion revascularization rates below 5% at 12 months; this reflects studied performance and is not an individual guarantee.
Clinical and Technical Context
The specific combination of wires, balloons, atherectomy, and stents is determined by the interventional cardiologist based on lesion complexity, calcification, and overall clinical picture. INVAMED's ATLAS Drug Eluting Coronary Stent System uses a cobalt-chromium L605 platform with 60 micrometer struts and a sirolimus coating dosed at 1 microgram per square millimeter with sustained controlled release. Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes. Guide extension catheters can provide the backup support needed to deliver devices in tortuous or distal anatomy. The need for extension support is judged case by case, since it depends on vessel geometry and the devices being delivered. Lesion calcification is a central factor in planning, and heavily calcified plaque may call for rotational atherectomy before ballooning or stenting. When a narrowing becomes flow-limiting, patients may experience angina on exertion, and an abrupt plaque rupture with thrombosis can precipitate a myocardial infarction. INVAMED's ATLAS system elutes sirolimus at 1 microgram per square millimeter with a sustained controlled-release profile designed to cover the early healing window.
Related on INVAMED
- Coronary Artery Disease & Cardiac Interventions — product category
- Atlas Coronary Stent System Stainless Steel: Features, Specifications and Clinical Role
- Coronary and CTO Guidewires: Technology, Uses and Considerations
- How long does a heart stent last?
Important Disclaimer
This content is educational and technical in nature and must not be interpreted as medical advice or as a promise of any clinical outcome. Individual results depend on many factors and can only be evaluated by a treating physician. Figures attributed to INVAMED reflect manufacturer or published data and are not a guarantee of results. All INVAMED devices are to be used by trained clinicians per the approved IFU, and availability is subject to local regulatory status.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.